BD Symposium at EUROGIN 2024
Screening Smarter - the US and European Experience using Extended Genotyping and Self-Collection
A global perspective on cutting-edge cervical cancer screening strategies
Join the BD symposium: Screening Smarter-the US and European Experience using Extended Genotyping and Self-Collection
EUROGIN 2024 March 14th 12:45-14:00 room A4
Join us as our panel shares real-world evidence and experiences of extended genotyping and self-collection.
Discover how cutting-edge screening strategies in the United States, Denmark and the Netherlands are advancing preventative healthcare.
Chair Dr. Kate Cuschieri
Director of Scottish HPV Research Group and Scottish HPV Reference Laboratory
Dr. Jeff Andrews MD, FRCSC
Vice President, BD Medical Affairs:
USA risk-based guidelines
Self-collect
NCI SHIP Trial
Jesper Bonde
Head of Molecular Pathology, Copenhagen University Hospital:
Danish cervical cancer screening extended genotyping and self-collection
Sandra van Dijk
Head of the Department of Cancer Screening, Dutch National Institute for Public Health and the Environment:
Evolution of Dutch cervical cancer screening and lessons learned
At EUROGIN 2024, explore how cervical cancer screening is evolving
The EUROGIN congress is a unique opportunity to meet and discuss with peers and industrial representatives how cervical cancer screening technologies are evolving.
Visit our booth B14 to learn more how at-home self-collection and extended genotyping are applied in screening programmes. Book an appointment with one of our medical experts now.
Book your appointment with a medical expert at EUROGIN 2024
